Prospect: information for the user
Galantamine Aurovitas Spain 24 mg prolonged-release hard capsules EFG
Read this prospect carefully before starting to take this medicine, as it contains important information for you.
1.What isGalantamine Aurovitas Spainand for what it is used
2.What you need to know before starting to takeGalantamine Aurovitas Spain
3.How to takeGalantamine Aurovitas Spain
4.Possible adverse effects
5.Storage ofGalantamine Aurovitas Spain
6.Contents of the package and additional information
Galantamina Aurovitas Spaincontains the active ingredient “galantamine”, an anti-dementia medication. It is used in adults to treat the symptoms of mild to moderately severe Alzheimer's disease, a type of dementia that alters brain function.
Alzheimer's disease causes an increase in memory loss, confusion, and changes in behavior, making it increasingly difficult to perform daily activities. It is thought that these effects are caused by a lack of “acetylcholine”, a substance responsible for transmitting messages between brain cells. Galantamine increases the amount of acetylcholine in the brain and thereby treats the symptoms of the disease.
The capsules are in the form of “prolonged release”. This means that they release the medication gradually.
Do not takeGalantamine Aurovitas Spain
Warnings and precautions
Consult your doctor or pharmacist before starting to take galantamine. This medication should only be used for Alzheimer's disease and is not recommended for other types of memory loss or confusion.
Severe side effects
Galantamine may cause severe skin reactions, heart problems, and seizures. Be aware of these side effects while taking galantamine. See section 4 “Be aware of severe side effects”.
Before starting treatment with galantamine, your doctor needs to know if you have or have had any of the following conditions:
Your doctor will decide if galantamine is suitable for you or if the dose needs to be changed.
Also inform your doctor if you have recently had surgeryon the stomach, intestine, or bladder. Your doctor will decide if galantamine is suitable for you.
Galantamine may cause weight loss.Your doctor will check your weight regularly while you are taking galantamine.
Children and adolescents
Galantamine is not recommended for use in children or adolescents.
Galantamine Aurovitas Spain with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Galantamine should not be taken with medications that act in the same way. These include:
Some medications may cause side effects with a higher probability in people taking galantamine. These include:
If you are taking any of these medications, your doctor may give you a lower dose of galantamine.
Galantamine may affect some anesthetics. If you are undergoing general anesthesia, inform your doctor in advance that you are taking galantamine.
Consult your doctor or pharmacist if you have any doubts.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Do not breastfeed while taking galantamine.
Driving and operating machinery
Galantamine may make you feel dizzy or drowsy, especially during the first few weeks of treatment. If galantamine affects you, do not drive or operate tools or machinery.
Galantamine Aurovitas Spain contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per capsule; it is essentially “sodium-free”.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
If you are taking galantamine tablets or oral solution and your doctor has told you that you will be switched to galantamine prolonged-release capsules, read carefully the instructions that appear in “Switching from galantamine tablets or oral solution to galantamine prolonged-release capsules” in this section.
How much to take
You will start treatment with galantamine at a low dose. The usual initial dose is 8 mg, once a day. Your doctor will gradually increase your dose, every 4 weeks or more, until you reach the most suitable dose. The maximum dose is 24 mg, once a day.
Your doctor will explain which dose you should start with and when to increase it. If you are unsure of what to do or find that the effect of galantamine is too strong or too weak, inform your doctor or pharmacist.
Your doctor needs to see you regularly to check that this medication is working and to discuss with you how you are feeling.
If you have liver or kidney problems,your doctor may give you a reduced dose of galantamine or may decide that this medication is not suitable for you.
Switching from galantamine tablets or oral solution to galantamine prolonged-release capsules
If you are currently taking galantamine tablets or oral solution, your doctor may decide to switch you to galantamine prolonged-release capsules. If this applies to you:
DO NOT take more than one capsule in a day. While taking a daily capsule of galantamine prolonged-release capsules, DO NOT take galantamine tablets or oral solution.
How to take
Galantamine capsules should be swallowed whole and NOT chewed or crushed. Take your dose of galantamine once a day in the morning, with water or other liquids. Try to take galantamine with food.
Drink plenty of liquid while taking galantamine to stay hydrated.
If you take more Galantamina Aurovitas Spain than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or
call the Toxicological Information Service, phone: 91 562 04 20 indicating the medication and the
amount ingested. Bring the packaging with the remaining capsules. Signs of overdose may include:
If you forgot to take Galantamina Aurovitas Spain
If you forgot to take a dose, leave that dose and continue treatment as usual with the next scheduled dose.Do not take a double dose to compensate for the missed doses.
If you forget to take more than one dose, consult your doctor.
If you interrupt treatment with Galantamina Aurovitas Spain
Consult with your doctor before interrupting treatment with galantamine. It is essential to continue taking this medication to treat your condition.
If you have any other questions about using this medication, ask your doctor or pharmacist.
Like all medications,this medicationcan cause side effects, although not everyone will experience them.
Be aware of severe side effects
Stop takingGalantamina Aurovitas Spainand consult a doctor or visit the nearest emergency service immediatelyif you notice any of the following side effects.
Skin reactions,including:
These skin reactions are rare in people taking galantamine (they can affect up to 1in every 1,000 people).
Heart problems,including changes in heart rhythm (such as slow heartbeat, extra beats) or palpitations (feeling a rapid or irregular heartbeat). Heart problems can be seen as an abnormal tracing on an “electrocardiogram” (ECG), and may be common in people taking galantamine (they can affect up to 1 in every 10 people).
Seizures. This is rare in people taking galantamine (they can affect up to 1 in every 100 people).
You should stop taking Galantamina Aurovitas Spain and seek help immediatelyif you notice any of the mentioned side effects.
Other side effects:
Frequent side effects(can affect more than 1 in every 10 people):
Common side effects(can affect up to 1 in every 10 people):
Rare side effects(can affect up to 1 in every 100 people):
Very rare side effects(can affect up to 1 in every 1,000 people):
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the blister or carton after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition ofGalantamina Aurovitas Spain
Each prolonged-release hard capsule contains 24 mg of galantamine (as hydrobromide).
Hard capsule content:microcrystalline cellulose, talc, hydroxypropyl cellulose, anhydrous colloidal silica, magnesium stearate.
Hard capsule coating:di oxide (E171), iron oxide red (E172), iron oxide yellow (E172), sodium lauryl sulfate, gelatin.
Printing ink:shellac, iron oxide black (E172).
Appearance of the product and contents of the package
Prolonged-release hard gelatin capsules of caramel opaque color, size 1, marked with “A” on the cap and “24” on the body, containing three white to off-white round biconvex tablets.
Galantamina Aurovitas Spain prolonged-release hard capsules are available in blister packs.
Package sizes:
Blister pack: 28 and 30 prolonged-release hard capsules.
Only some package sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Responsible manufacturer:
APL Swift Services (Malta) Limited
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
O
Generis Farmacêutica, S.A.
Rua João de Deus, 19
Amadora 2700-487
Portugal
This medicine is authorized in the member states of the European Economic Area with the following names:
Spain:Galantamina Aurovitas Spain 24 mg prolonged-release hard capsules EFG
Netherlands:Galantamine Aurobindo Retard 24 mg, hard capsules with prolonged release
Portugal:Galantamina Aurovitas
Last review date of this leaflet: December 2022
Further information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es)
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.